89bio Appoints Charles McWherter, Ph.D., to its Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
89bio Inc. (ETNB) PT Lowered to $12 at RBC Capital
August 6, 2024 6:41 AM EDTRBC Capital analyst Brian Abrahams lowered the price target on 89bio Inc. (NASDAQ: ETNB) to $12.00 (from $13.00) while maintaining a Sector Perform rating.
The analyst comments "Both ph.III studies in MASH have been initiated and are enrolling. While we like pegoza's likely role... More



